To Evaluate the Safety and Efficacy of TQB2618 Injection Combined With Penpulimab in the Treatment of Patients With Relapsed and Refractory Lymphoma
Clinical trial NCT05400876 · UNKNOWN
Trial details
- NCT number
- NCT05400876
- Sponsor
- Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-06-09
- Primary completion
- 2023-05-01
- Enrollment
- 92
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.